Correction: PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis

August, 08, 2024 | Select Oncology Journal Articles

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –

Advertisement

LATEST

Proapoptotic Potential of MAC-NCs in Gastric Cancer Cells

Proapoptotic Potential of MAC-NCs in Gastric Cancer Cells

Sep 20, 2024

Boron Neutron Capture Therapy for Spinal Tumors

Boron Neutron Capture Therapy for Spinal Tumors

Sep 20, 2024

Venetoclax and Hypomethylating Agents in Coexisting MM and AML

Venetoclax and Hypomethylating Agents in Coexisting MM and AML

Sep 20, 2024

New Bioinformatics-Based Model for Cervical Cancer Diagnosis

New Bioinformatics-Based Model for Cervical Cancer Diagnosis

Sep 20, 2024

Advertisement

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Newsletter

Privacy Policy